Table 1.
No. | Endolysin Name | Original Phage | Targeted Pathogens | Effective Concentration | Features of Endolysin | Reference |
---|---|---|---|---|---|---|
1 | LysMR-5 | S. aureus phage | S. aureus, S. epidermidis | 500 μg/mL | encapsulation in alginate-chitosan nanoparticles | [59] |
2 | LysRODI | S. aureus phage | S. aureus | 20 µg/mL | encapsulation in pH-sensitive liposomes, and effective at pH 5 | [60] |
3 | XZ.700 | S. aureus phage | S. aureus | 250 µg/mL | chimeric endolysin and effective against S. aureus biofilms | [61] |
4 | LysSAP26 | S. aureus phage SAP-26 | A. baumannii, E. coli, K. pneumoniae, P. aeruginosa, S. aureus, E. faecium | 5–80 µg/mL | there was 40% protection rate in A. baumannii-infected mouse model | [62] |
5 | Lys84 | S. aureus phage qdsa002 | S. aureus | 10 μM | effective against biofilms | [63] |
6 | LysSAP33 | S. aureus phage SAP33 | S. aureus | / | higher activity against biofilms than LysK-like endolysin | [64] |
7 | S25-3 | S. aureus kayvirus S25-3 | S. aureus | / | genus-specific against staphylococci, particularly S. aureus | [65] |
8 | SAL200 | S. aureus phage | S. aureus | / | effective against severe pneumonia caused by S. aureus in a lethal murine model | [66] |
9 | LysCSA13 | S. aureus phage | S. aureus | 300 nM | effective against staphylococcal biofilms on various food contact surfaces | [67] |
10 | Lys109 | S. aureus phage | S. aureus | 100 nM | chimeric endolysin | [68] |
11 | LysP108 | S. aureus phage | S. aureus | / | / | [69] |
12 | ClyC | S. aureus phage | S. aureus | / | chimeric endolysin | [70] |
13 | HY-133 | S. aureus phage | S. aureus | 0.12–0.5 μg/mL | chimeric endolysin | [71] |
14 | LysSA11 | staphylococcal phage SA11 | S. aureus | / | expressed and surface-displayed in Saccharomyces cerevisiae | [72] |
15 | Ph28 | S. epidermidis phage PH15 | S. epidermidis | / | / | [73] |
16 | MSlys | S. pneumoniae phage MS1 | S. pneumoniae | 2 μM | / | [74] |
17 | LyJH307 | Streptococcus bovis phage | S. bovis, E. faecalis, S. sanguinis | 50 µg/mL | highest efficacy at pH 5.5 at 39 °C | [75] |
18 | LyJH307 | S. bovis | S. bovis | / | as a specific modulator for rumen | [76] |
19 | PlyC | streptococcal C1 phage | group A, C, and E streptococci | / | recognition of Streptococcus Group A carbohydrate backbone | [77] |
20 | LytSD | S. avermitilis phage phiSASD1 | S. avermitilis, B. subtilis, S. aureus, S. lutea, E. faecalis | 10 μg/mL | / | [78] |
21 | lys46 | B. subtilis phage | K. pneumoniae, S. Typhimurium, Proteus, E. coli | / | / | [79] |
22 | Ply57 | broad-host-range temperate phage, Izhevsk | B. cereus group | 1 μM | thermostability at 55 °C | [80] |
23 | LysPBC5 | B. cereus phage PBC5 | B. cereus | / | / | [81] |
24 | PlyB | B. anthracis phage vB_BanS_Bcp1 | B. cereus sensu lato group species | 16 µg/mL | potent bacteriolytic activity against all B. cereus sensu lato isolates | [82] |
25 | LysB4EAD-LysSA11 | B. cereus phage B4 + S. aureus phage SA11 | S. aureus, B. cereus | 3.0 µM | a hybrid endolysin | [33] |
26 | LysPBC2 | B. cereus phage PBC2 | Bacillus, Listeria, Clostridium | / | harboring a B. cereus spore binding domain | [30] |
27 | CTP1L | C. tyrobutyricum phage ΦCTP1 | C. tyrobutyricum | / | the endolysin encoding gene was introduced into the nisin producer Lactococcus lactis subsp. lactis INIA 415 | [83] |
28 | LysCPAS15 | C. perfringens phage CPAS-15 | C. perfringens | 45 µg/mL | C. perfringens-specific, used for pathogen detection | [84] |
29 | CWH | C. difficile phage phiMMP01 | C. difficile | / | cell wall binding domain prevents C. difficile spore outgrowth | [85] |
30 | Psa | C. perfringens phage st13 | C. perfringens | / | an amidase endolysin that specifically lyses C. perfringens | [86] |
31 | LysIME-EF1 | E. faecalis phage | E. faecalis | / | a novel two-component endolysin encoded by a single gene | [87] |
32 | ORF28 endolysin | E. faecalis phage ϕEf11 | E. faecalis | 15–31 μg/mL | multifunctional lytic enzyme, effective against E. faecalis biofilm | [88] |
33 | Lys08 | E. faecalis phage PHB08 | E. faecalis | 0.5–1 µg/mL | effective against E. faecalis biofilms | [89] |
34 | EG-LYS | E. faecalis phage | E. faecalis | 0.1 mg/mL | specific to E. faecalis | [90] |
35 | PBEF129 endolysin | E. faecalis phage PBEF129 | E. faecalis | 4.8 µM | effective against biofilm | [91] |
36 | PM-477 | Gardnerella prophage | Gardnerella | 0.13–8 µg/mL | no effect on beneficial lactobacilli or other species of vaginal bacteria | [92] |
37 | LysKB317 | Lactobacillus phage EcoSau | Acetobacter, Lactobacillus, Pediococcus, Streptococcus, Weissella | 0.01–1 µM | broad activity and stability from pH 4.5–7.5 up to at least 48 h; maximum activity is observed at 50 °C up to at least 72 h | [93] |
38 | 293 endolysin | L. monocytogenes phage vB_LmoS_293 | L. monocytogenes 473 and 3099, a serotype 4b and serogroup 1/2b-3b-7 | / | amidase | [94] |
39 | LysA | mycobacteriophage D29 | M. smegmatis | / | separation of M. smegmatis from a mixed culture via the cell wall binding domain | [95] |
40 | LysP11 | Propionibacterium phage P1.1 | E. rhusiopathiae | / | binding specifically to the E. rhusiopathiae cell wall | [96] |
41 | PlyPl23 | P. larvae phage phiIBB_Pl23 | P. larvae | / | first highly specific CBD targeting exclusively P. larvae cells | [97] |
Note: “/” indicates data inaccessible.